transgene enabled cell-based therapeutics (ZIOPHARM Oncology/Mesoblast/Intrexon)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Nametransgene enabled cell-based therapeutics (ZIOPHARM Oncology/Mesoblast/Intrexon)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAustralia and New Zealand
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAlaunos Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMesoblast LtdAlaunos Therapeutics IncPrecigen Inc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A